Bayside Biosciences
San Diego, United States· Est. 2019
Develops novel immunotherapies and targeted therapies for cancer treatment.
Private Company
Total funding raised: $38M
About
Develops novel immunotherapies and targeted therapies for cancer treatment.
OncologyImmunology
Funding History
2Total raised:$38M
Series A$30MApr 15, 2022
Seed$8MJan 15, 2020